Surgery Partners, Inc. SGRY

14.40 0.20 1.41% as of 25 Sep
Market cap
$1.9B
P/E
0.0×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Revenue
1,145.44 1,341.20 1,771.50 1,831.40 1,860.10 2,225.10 2,539.30 2,743.30 3,114.30 3,308.70
Revenue Growth
19.33% 17.09% 32.08% 3.38% 1.57% 19.62% 14.12% 8.03% 13.52% 6.24%
Cost of Revenue
821.20 1,013.80 1,361.40 1,407.60 1,480.30 1,733.70 1,964.40 2,095.80 2,368.70 2,543.70
Gross Profit
324.24 327.40 410.10 423.80 379.80 491.40 574.90 647.50 745.60 765.00
SG&A Expenses
60.25 76.00 93.60 88.60 50.90 66.10 102.20 120.90 138.70 118.20
Operating Income
196.48 158.30 77.80 235.90 183.00 302.20 345.20 328.00 348.80 389.50
Non-operating Income/Expense
(104.30) (76.00) (147.00) (181.30) (201.80) (221.00) (234.90) (193.00) (201.70) (272.60)
Non-operating Interest Expenses
100.57 117.70 147.00 178.90 201.80 221.00 234.90 193.00 201.70 272.60
EBT
92.18 82.30 (69.20) 54.60 (18.80) 81.20 110.30 135.00 147.10 116.90
Income Tax Provision
7.10 53.60 26.40 9.50 (20.10) 10.50 23.30 (0.30) 134.60 18.00
Income after Tax
85.08 28.70 (95.60) 45.10 1.30 70.70 87.00 135.30 12.50 98.90
Dividends (Preferred)
— 26.10 32.40 35.70 39.50 10.30 0.00 0.00 — —
Non-Controlling Interest
75.63 81.70 110.10 119.90 117.40 141.60 141.60 147.20 180.60 176.80
Net Income Common
9.45 (79.10) (238.10) (110.50) (155.60) (81.20) (54.60) (11.90) (168.10) (77.90)
EPS (Basic)
0.20 (1.64) (4.96) (2.27) (3.19) (1.12) (0.59) (0.09) (1.33) (0.61)
EPS (Diluted)
0.20 (1.64) (4.96) (2.27) (3.19) (1.12) (0.59) (0.09) (1.33) (0.61)
Shares (Basic, Weighted)
48.02 48.32 48.03 48.28 48.78 72.43 91.95 125.61 126.12 127.21
Shares (Diluted, Weighted)
48.19 48.32 48.03 48.28 48.78 72.43 91.95 125.61 126.12 127.21
Gross Margin
28.31% 24.41% 23.15% 23.14% 20.42% 22.08% 22.64% 23.60% 23.94% 23.12%
EBIT Margin
17.57% 12.28% 4.89% 13.44% 10.42% 14.09% 14.09% 12.47% 11.83% 12.46%
EBT margin
8.05% 6.14% (3.91%) 2.98% (1.01%) 3.65% 4.34% 4.92% 4.72% 3.53%
Net Profit Margin
0.83% (5.90%) (13.44%) (6.03%) (8.37%) (3.65%) (2.15%) (0.43%) (5.40%) (2.35%)
Free Cash Flow Margin
7.52% 6.81% 7.00% 4.01% 14.11% 1.60% 3.59% 8.41% 6.82% 7.32%
EBITDA
240.80 216.60 154.10 322.60 288.60 412.30 472.50 460.30 520.90 588.40
EBIT
201.25 164.70 86.70 246.10 193.80 313.50 357.70 342.20 368.30 412.40
Income from Continuous Operations
85.08 28.70 (95.60) 45.10 1.30 70.70 87.00 135.30 12.50 98.90
Consolidated Net Income/Loss
85.08 28.70 (95.60) 45.10 1.30 70.70 87.00 135.30 12.50 98.90
EPS (Basic, from Continuous Ops)
1.77 0.59 (1.99) 0.93 0.03 0.98 0.95 1.08 0.10 0.78
EPS (Basic, Consolidated)
1.77 0.59 (1.99) 0.93 0.03 0.98 0.95 1.08 0.10 0.78
EPS (Diluted, from Cont. Ops)
1.77 0.59 (1.99) 0.93 0.03 0.98 0.95 1.08 0.10 0.78
Shares (Diluted, Average)
48.19 48.19 48.03 48.28 48.78 72.43 91.95 125.61 126.12 127.21
EPS (Diluted, Consolidated)
1.77 0.59 (1.99) 0.93 0.03 0.98 0.95 1.08 0.10 0.78
EBITDA Margin
21.02% 16.15% 8.70% 17.61% 15.52% 18.53% 18.61% 16.78% 16.73% 17.78%
Operating Cash Flow Margin
10.93% 9.01% 8.16% 7.07% 13.27% 3.91% 6.25% 10.71% 9.64% 8.29%

Fold the line items

In millions of $ except per-share values · columns are period end dates